Tag Archives: The Stem Cell Blog

Russian stem cell transplants give Kiwi MS sufferers hope – New Zealand Herald

Continue reading

2017-11-06 NEWS

New Zealand Herald

Russian stem cell transplants give Kiwi MS sufferers hope
New Zealand Herald
Radical new treatment for multiple sclerosis is being credited for getting a New Zealand woman’s life on track. After undergoing stem cell treatment in May, Howick mother-of-two Faye Braddock has returned from Moscow feeling like she’s a new woman.

Continue reading

2017-11-06 NEWS

New Zealand Herald

Russian stem cell transplants give Kiwi MS sufferers hope
New Zealand Herald
Radical new treatment for multiple sclerosis is being credited for getting a New Zealand woman’s life on track. After undergoing stem cell treatment in May, Howick mother-of-two Faye Braddock has returned from Moscow feeling like she’s a new woman.

Continue reading

2017-11-06 NEWS

Los Angeles Business Journal

Children’s Hospital to Lead Immunotherapy Study
Los Angeles Business Journal
… the Program for Cell Enhancement and Technologies for Immunotherapy at the Children’s National Health System. Health business reporter Dana Bartholomew can be reached at dbartholomew@labusinessjournal.com. Follow him on Twitter @_DanaBart.

and more »

Continue reading

2017-11-06 NEWS

Medical Xpress

Stem cells pave the way for new treatment of diabetes
Medical Xpress
A new stem cell study conducted at the University of Copenhagen shows how we may increase the vital production of insulin in patients suffering from diabetes. The discovery helps to more efficiently at less cost make insulin-producing beta cells from
Global Stem Cell Storage Market – Positive long-term growth outlook 2017-2022Medgadget (blog)
Global Stem Cell Media Market 2018-2023: Thermo Fisher, STEMCELL Technologies and Merck MilliporeHitechexaMiner (press release)
Diabetes’ days are numberedInnovators Magazine
satPRnews (press release) –PostObserver
all 19 news articles »
Continue reading

2017-11-06 NEWS

Muscular Dystrophy News

FDA Clears IND Application for GALGT2 Gene Therapy for Duchenne Muscular Dystrophy
Muscular Dystrophy News
The U.S. Food and Drug Administration (FDA) recently cleared an investigational new drug (IND) application for the GALGT2 gene therapy program for Duchenne muscular dystrophy (DMD) filed by Sarepta Therapeutics and Nationwide Children’s Hospital.
Sarepta Therapeutics (SRPT): FDA Clears GALGT2 Gene Therapy Program – William BlairStreetInsider.com
Sarepta Therapeutics and Nationwide Children’s Hospital Announce FDA Clearance of IND for Micro-Dystrophin GeneMarkets Insider
Sarepta Therapeutics And Nationwide Children’s Hospital Announce US Food And Drug Administration (FDA …Clinical Leader

all 18 news articles »